According to a survey from Leger Healthcare, 8% of respondents are currently on a prescription GLP-1
doi:10.1021/acsinfecdis.0c00288 Ghezzi P, Lemley KV, Andrus JP, De Rosa SC, Holmgren A, Jones D, Jahoor F, Kopke R, Cotgreave I, Bottiglieri T, Kaplowitz N, Nakamura H, Staal F, Ela SW, Atkuri KR, Tirouvanziam R, Heydari K, Sahaf B, Zolopa A, Frye RE, Mantovani JJ, Herzenberg LA, Herzenberg LA
Currently, there is no official FDA indication for GLP-1 receptor agonists specifically targeting inflammation, and clinical guidelines do not recommend this approach outside established indications
Nature 2012
This pathway is regulated by insulin, which promotes the activation of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), the key enzymes in fatty acid synthesis
Nature 387 : 299303 Lee YI, Han YJ, Lee SY, Park SK, Park YJ, Moon HB, Shin JH, Lee JH (2003) Activation of insulin-like growth factor II signaling by mutant type p53: physiological implications for potentiation of IGF-II signaling by p53 mutant 249